Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial
Paul Little(University of Antwerp), Theo Verheij(Utrecht University), Francesco Blasi(University of Milan), Samuel Coenen(University of Antwerp), Artur Mierzecki(Pomeranian Medical University), An De Sutter(Ghent University), Herman Goossens(Kaneka (United States)), P Touboul(Université Côte d'Azur), Mark Mullee(University of Southampton), Janko Kersnik(University of Maribor), Sławomir Chlabicz(Medical University of Białystok), Michael Moore(Indiana University School of Medicine), Gilly O’Reilly(University of Southampton), Christopher Butler(University of Oxford), Helena Hupková(Comenius University Bratislava), Sigvard Mölstad(Region Jönköpings län), Maciek Godycki-Ćwirko(Medical University of Lodz), Mel Davies, Beth Stuart(Queen Mary University of London), Antoni Torres(Instituto de Salud Carlos III), Tom Schaberg(Saxon Police Force), Kerenza Hood(NHS Digital), Curt Brugman(University Medical Center Utrecht), Jordi Almirall(Hospital Sant Jaume de Calella)
Cited by 227
Related Papers
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
|Proceedings of the National Academy of Sciences|2018|3.2k
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
|New England Journal of Medicine|2015|1.2k
Guidelines for the management of adult lower respiratory tract infections - Full version
|Clinical Microbiology and Infection|2011|948
Risk factors for community-acquired pneumonia in adults in Europe: a literature review
|Thorax|2013|861
Tailored interventions to address determinants of practice
|Cochrane Database of Systematic Reviews|2015|735